#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	17650	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2684	807.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1714	1714	C	1121	C,T,A	1116,3,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29426	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4207	873.6	0	.	n	.	0	T695C	SNP	695	695	T	1394	1394	C	1095	C	1095	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29426	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4207	873.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	2036	2036	A	1235	A,G,T	1232,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29426	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4207	873.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2670	2670	C	983	C,A	981,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29426	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4207	873.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2744	2744	A	924	A,T	922,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29426	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4207	873.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3296	3296	C	1097	C,T	1093,4	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2544	folP	852	852	100.0	folP.l15.c4.ctg.1	2016	157.1	1	SNP	p	R228S	1	.	.	682	684	AGC	1249	1251	AGC	243;243;246	A;G;C	243;243;246	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5654	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3876	182.1	1	SNP	p	S91F	0	.	.	271	273	TCC	787	789	TCC	225;223;227	T,G;C;C	224,1;223;227	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5654	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3876	182.1	1	SNP	p	D95G	0	.	.	283	285	GAC	799	801	GAC	233;235;233	G,T;A,G;C,T	232,1;234,1;232,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5654	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3876	182.1	1	SNP	p	D95N	0	.	.	283	285	GAC	799	801	GAC	233;235;233	G,T;A,G;C,T	232,1;234,1;232,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	2188	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1914	142.7	0	.	p	.	0	A39T	NONSYN	115	117	GCC	797	799	ACC	213;214;210	A,G;C;C	210,3;214;210	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	2188	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1914	142.7	0	.	p	.	0	R44H	NONSYN	130	132	CGC	812	814	CAC	203;205;205	C;A,G;C	203;202,2;204	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	2188	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1914	142.7	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	995	997	CAC	276;274;273	C;A;C	276;274;273	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	2188	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1914	142.7	1	SNP	p	G45D	0	.	.	133	135	GGC	815	817	GGC	202;201;204	G;G,A;C	201;199,1;203	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1240	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1589	97.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5870	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3480	210.6	1	SNP	p	D86N	0	.	.	256	258	GAC	785	787	GAC	276;276;273	G;A,G;C,G	276;275,1;272,1	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5870	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3480	210.6	1	SNP	p	S87W	0	.	.	259	261	AGT	788	790	AGT	273;275;277	A;G;T	273;275;277	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5870	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3480	210.6	1	SNP	p	S87R	0	.	.	259	261	AGT	788	790	AGT	273;275;277	A;G;T	273;275;277	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5870	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3480	210.6	1	SNP	p	S87I	0	.	.	259	261	AGT	788	790	AGT	273;275;277	A;G;T	273;275;277	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5870	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3480	210.6	1	SNP	p	S88P	0	.	.	262	264	TCC	791	793	TCC	279;280;283	T;C;C	279;280;283	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5070	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3200	197.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1762	1764	GGC	278;277;277	G,T;G;C	277,1;277;277	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4610	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2962	194.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1561	1563	GCA	257;259;258	G;C;A	257;259;258	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4610	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2962	194.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1564	1566	ATC	259;261;263	A;T;C	259;261;263	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4610	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2962	194.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1576	1578	GTG	267;270;268	G,A;T;G	266,1;270;268	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4610	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2962	194.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1576	1578	GTG	267;270;268	G,A;T;G	266,1;270;268	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4610	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2962	194.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2080	2082	ACC	252;252;251	A,C;C;C	251,1;252;251	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4610	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2962	194.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2134	2136	GCG	215;215;220	G;C;G,T,C	215;215;218,1,1	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4610	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2962	194.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2134	2136	GCG	215;215;220	G;C;G,T,C	215;215;218,1,1	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4610	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2962	194.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2257	2259	GGC	229;228;227	G,T;G,T;C	227,2;227,1;227	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4610	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2962	194.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2266	2268	GGC	227;231;232	G;G,T;C	227;230,1;232	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4610	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2962	194.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2284	2286	CCG	241;238;243	C,G;C;G	240,1;238;243	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6614	ponA	2397	2397	99.96	ponA.l15.c17.ctg.1	3584	230.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2868	porA	1146	1146	99.83	porA.l6.c30.ctg.1	2227	160.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	767	767	C	182	C,A	181,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3434	porB1b	1035	1035	96.1	porB1b.l15.c17.ctg.1	1733	244.3	0	.	p	.	0	E48G	NONSYN	142	144	GAA	591	593	GGA	313;314;315	G;G;A	313;314;315	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3434	porB1b	1035	1035	96.1	porB1b.l15.c17.ctg.1	1733	244.3	0	.	p	.	0	F135L	NONSYN	403	405	TTT	852	854	CTT	262;260;265	C;T;T	262;260;265	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3434	porB1b	1035	1035	96.1	porB1b.l15.c17.ctg.1	1733	244.3	0	.	p	.	0	R143G	NONSYN	427	429	AGA	876	878	GGA	270;268;267	G,T;G;A,T	269,1;268;266,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3434	porB1b	1035	1035	96.1	porB1b.l15.c17.ctg.1	1733	244.3	0	.	p	.	0	D171G	NONSYN	511	513	GAT	960	962	GGT	312;311;313	G;G,T;T,C	312;310,1;312,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3434	porB1b	1035	1035	96.1	porB1b.l15.c17.ctg.1	1733	244.3	0	.	p	.	0	G189S	NONSYN	565	567	GGC	1014	1016	AGC	288;290;285	A;G,A;C	288;289,1;285	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3434	porB1b	1035	1035	96.1	porB1b.l15.c17.ctg.1	1733	244.3	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1080	1080	T	251	T	251	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3434	porB1b	1035	1035	96.1	porB1b.l15.c17.ctg.1	1733	244.3	1	SNP	p	G120K	0	.	.	358	360	GGT	807	809	GGT	260;262;267	G,C;G;T,A	259,1;262;266,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3434	porB1b	1035	1035	96.1	porB1b.l15.c17.ctg.1	1733	244.3	1	SNP	p	A121N	0	.	.	361	363	GCC	810	812	GCC	268;269;271	G,A;C;C	267,1;269;271	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3434	porB1b	1035	1035	96.1	porB1b.l15.c17.ctg.1	1733	244.3	1	SNP	p	A121D	0	.	.	361	363	GCC	810	812	GCC	268;269;271	G,A;C;C	267,1;269;271	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11528	rpoB	4179	4179	100.0	rpoB.l6.c17.ctg.1	5301	271.4	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2226	2228	AAT	294;291;291	A;A,C;T	294;290,1;291	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1686	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1444	145.3	1	SNP	p	V57M	1	.	.	169	171	ATG	745	747	ATG	302;302;302	A;T;G	302;302;302	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
